Introduction
Agenix Limited is a biopharmaceutical company based in Melbourne, Australia. Through its wholly owned subsidiaries, Agen Biomedical and Agenix Biopharmaceutical (Shanghai), the Company has a strategic goal of building and developing a line of therapeutic and imaging products, and this is evidenced by the company’s heavy investment in research and development as it seeks to develop new biopharmaceutical products appropriate for its market1. The company is listed in the Australian stock Exchange (ASX), having been listed in 1987. The company’s shares are also available the NASDAG.
Disclosure Index for Agenix Limited
Financial disclosure is the deliberate release of numerical or qualitative financial and non financial ...